MedPath

Mandibular advancement device (MAD) therapy in edentulous patients with obstructive sleep apnea: dental implant retained MAD therapy

Recruiting
Conditions
Obstructive sleep apnea syndrome
sleep apnea
10046304
10019190
Registration Number
NL-OMON47940
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
38
Inclusion Criteria

Male of female - Age 18 - 75 years - Sufficient understanding of Dutch language
in speaking and writing. - Completely (mandibular and maxillary) edentate with
or without dental implants - Diagnosed with moderate OSA (AHI between 15 - 30)
or unsuccessfully treated with CPAP with moderate or severe OSA (AHI > 15) - No
previous OSA therapy, except CPAP

Exclusion Criteria

Craniofacial deformities - Medication use related to a sleeping disorder -
Evidence of respiratory/sleep disorders other than OSA (eg. central sleep apnea
syndrome). - Reversible morphological upper airway abnormalities (e.g. enlarged
tonsils). - Temporomandibular disorders

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>AHI (baseline vs. 3 months): apnea hypopnea Index (AHI) derived from<br /><br>standardized polysomnography studies at baseline and 3 months after CPAP<br /><br>treatment initiation (control-group) or MAD therapy initiation (intervention<br /><br>group).</p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath